USAspending · Contract award
BCRX: Department of Veterans Affairs contract award
ORLADEYO 150MG CAP
Follow BCRX- First observed
- Nov 8, 2026, 6:14 PM EST
- Event / period date
- May 19, 2026
- Collected
- Nov 8, 2026, 6:14 PM EST
Why this is connected
Exact legal-name match: BIOCRYST PHARMACEUTICALS INC (https://www.sec.gov/Archives/edgar/data/882796/).
Reported contract amount
$151,464.65
Source last modified: May 19, 2026
Award Amount is total obligations on this award, not a new incremental commitment or contract ceiling.
Source evidence
Read the source excerpt or record
{"internal_id":358467476,"Award ID":"36C26026F0294","Recipient Name":"BIOCRYST PHARMACEUTICALS INC","Award Amount":151464.65,"Description":"ORLADEYO 150MG CAP","Awarding Agency":"Department of Veterans Affairs","Start Date":"2026-05-19","Last Modified Date":"2026-05-19 13:47:46","generated_internal_id":"CONT_AWD_36C26026F0294_3600_36F79721D0166_3600","awarding_agency_id":561,"agency_slug":"department-of-veterans-affairs"}Price change after we could observe it
+0.26% BCRX
Adjusted closing prices from Nov 9, 2026 to Nov 11, 2026. SPY changed 0.95% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.
Congressional trading in BCRX
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Sep 4, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought BioCryst Pharmaceuticals BCRX
$1K–$15K · Traded Jul 10, 2026 · disclosed Sep 4, 2026 · filed 56 days later
- Dec 15, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought BioCryst Pharmaceuticals BCRX
$1K–$15K · Traded Nov 13, 2025 · disclosed Dec 15, 2025
- Nov 11, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Bought BioCryst Pharmaceuticals BCRX
$1K–$15K · Traded Oct 16, 2023 · disclosed Nov 11, 2023 · Joint
- Oct 15, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold BioCryst Pharmaceuticals BCRX
$1K–$15K · Traded Sep 15, 2023 · disclosed Oct 15, 2023 · Joint
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.